Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 424286011000036118 | intestinal gel | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 424287011000036115 | intestinal gel dose form (AU qualifier) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| intestinal gel | Is a | gel | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Duodopa gel: intestinal | has manufactured dose form | False | intestinal gel | Inferred relationship | Some | |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL gel: intestinal | has manufactured dose form | False | intestinal gel | Inferred relationship | Some | |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | has manufactured dose form | True | intestinal gel | Inferred relationship | Some | |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | has manufactured dose form | True | intestinal gel | Inferred relationship | Some |
This concept is not in any reference sets
FHIR